Galapagos NV (FRA:GXE)
€ 26.28 0.4 (1.55%) Market Cap: 1.74 Bil Enterprise Value: -1.59 Bil PE Ratio: 8.43 PB Ratio: 0.61 GF Score: 49/100

Galapagos NV at Citi Biopharma Conference (Virtual) Transcript

Sep 09, 2021 / 01:45PM GMT
Release Date Price: €50.34 (-0.75%)
Peter Verdult
Citigroup Inc., Research Division - MD

So good afternoon, everyone. Sorry for the slight delay, technical difficulties. Bart, myself and the team were in separate rooms. But we're here now, day 2 of Citi's BioPharma Conference. It's Pete Verdult here. And on behalf of the team, I'm delighted to introduce Bart Filius, President and COO of Galapagos, along with the IR team. Bart's going to make some introductory remarks before we head into Q&A. As I always say, I'm here to moderate, not to monopolize. So you do have the function on screen to submit your questions. They will be e-mailed through to me or you can just e-mail me direct or make sure anything that comes through gets put to Bart and the team.

So without further ado, Bart, over to you.

Bart Filius
Galapagos NV - President, COO & Member of Management Board

Yes. Hi, Peter, and thanks for having me in the conference. Pleasure, as always, to speak with you and the rest of the audience. Indeed, I thought it would be good to just take you through a couple of slides, roughly 10

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot